Herpesviruses are a common virus infecting man. Twodrugs have shown clinical efficacyin the treatment of herpesvirus infections, acyclovir and ganciclovir. Acyclovir has excellent antiviral activity against herpes simplex types 1 and 21}; ganciclovir is potent against human cytomegalovirus2). Both drugs are nucleoside analogs and are metabolized to their respective triphosphates which then block viral DNA replication by inhibiting the viral DNA polymerase3'4).
Wehave developed a natural product screen to search for non-nucleotide inhibitors of viral DNA polymerases. Herpes simplex type 1 (HSV-1) DNA polymerase is a good target since the viral polymerase is well characterized5) and few natural products are knownto interfere with the assay. The strategy of the screen is to identify novel compounds that inhibit HSV-1 DNA polymerase to a significantly greater degree than the enzymes from bacteria and mammalian cells. Nonspecific inhibitors that might interfere with the enzyme-based assay are eliminated by extraction of the fermentation broth with ethyl acetate. High MWspecies are also eliminated by size exclusion filtration. This screen has led to the identification of the dibenzoquinone, oosporein6) as a selective inhibitor of HSV-1 DNApolymerase. A structurally related compound,gossypol, was also found to preferentially inhibit HSV-1 DNApolymerase. Oosporein is produced by a fungal soil isolate that was identified as Beauvaria sp. and deposited as SCI5097 in our culture collection.
To produce oosporein, a germinator culture was grown in a medium of the following composition: malt extract 1%, yeast extract 1%, peptone 0.1% and glucose 2%. The fermentation proceeded for 72hours at 25°C on a rotary shaker. This culture then served as the source ofinoculum (5%) for the fermentation FEB. 1992 that was done with the same mediumand conditions as used for the germinator. At harvest, the fermentation broth was centrifuged to remove the mycelia, the supernatant adjusted to pH 3 with HC1 and extracted with ethyl acetate. The ethyl acetate layer was evaporated in vacuo to a residue that was then dissolved in a small volume of methanol. Oosporein crystallized from methanol -water as red needles that were subsequently collected by filtration ( Further studies with HSV-1 DNApolymerase were performed to investigate the mechanismof inhibition by oosporein. Oosporein was determined to be a noncompetitive inhibitor of dGTPor dCTP incorporation into DNA (data not shown). In contrast, oosporein is a competitive inhibitor with respect to the DNAsubstrate (Fig. 2) . The inhibition constant for oosporein was determined to be 30 /xm The lack of inhibition of topoisomerase I and DNAgyrase suggests that this is not the case; neither of these enzymes was inhibited by oosporein up to 100/xg/ml (327jim) (data not shown). In addition, the gel electrophoretic analysis
shows that oosporein does not break phosphodiester bonds in the DNA. The related compound, gossypol behaves similarly to oosporein; inhibition is noncompetitive with respect to dNTPsand competitive with respect to DNA (Fig. 3) . The inhibition of HSV-1 DNA polymerase is more potent with an inhibition constant of 4^M. Gossypol has previously been shown to inhibit HSV-2 growth in cell culture; the mechanism of antiviral action was suggested to occur at the virion envelope since the nonenveloped poliovirus was not affected12 merase a activity. Gossypol inhibition is noncompetitive with respect to deoxynucleotide triphosphates and competitive with respect to activated calf thymus DNA, the same pattern of inhibition we observe with HSV-1 DNApolymerase. Under our assay conditions, the inhibition we observe with HSV-1 DNApolymerase is much greater than the inhibition of HeLa DNApolymerase activity and suggest that gossypol interacts with HSV-1 and HSV-2 DNApolymerases differently.
